ZyVersa Therapeutics (ZVSA) Institutional Ownership $0.67 -0.03 (-4.00%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$0.67 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ZyVersa Therapeutics (NASDAQ:ZVSA)CurrentInstitutional OwnershipPercentage3.91%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$26.77KNumber ofInstitutional Sellers(last 12 months)0 Get ZVSA Insider Trade Alerts Want to know when executives and insiders are buying or selling ZyVersa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZyVersa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025Virtu Financial LLC25,259$27K0.0%N/A1.079% 7/27/2023Virtu Financial LLC120,377$30K0.0%N/A0.595% 4/17/2023Winthrop Advisory Group LLC13,361$26K0.0%N/A0.145% (Data available from 1/1/2016 forward) ZVSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVSA shares? During the previous two years, the following institutional investors and hedge funds held shares of ZyVersa Therapeutics shares: Virtu Financial LLC ($27K).Learn more on ZyVersa Therapeutics' institutional investors. What percentage of ZyVersa Therapeutics' stock is owned by institutional investors? 3.91% of ZyVersa Therapeutics' stock is owned by institutional investors. Learn more on ZVSA's institutional investor holdings. Which institutional investors have been buying ZyVersa Therapeutics' stock? The following institutional investors have purchased ZyVersa Therapeutics' stock in the last 24 months: Virtu Financial LLC ($145.64K). How much institutional buying is happening at ZyVersa Therapeutics? Institutional investors have bought a total of 25,259 shares in the last 24 months. This purchase volume represents approximately $26.77K in transactions. Related Companies EYEN Major Shareholders ALVR Major Shareholders ATHA Major Shareholders IBIO Major Shareholders EQ Major Shareholders CTXR Major Shareholders BGXX Major Shareholders PHIO Major Shareholders BCDA Major Shareholders TRIB Major Shareholders This page (NASDAQ:ZVSA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.